Operating Income: The income after operating expenses.
Oric Pharmaceuticals, Inc. (ORIC) had Operating Income of $-39.06M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-36.35M |
|
-- |
|
-- |
|
$39.06M |
|
|
Operating Income |
$-39.06M |
$2.71M |
|
$-36.35M |
|
$-36.35M |
|
$-36.35M |
|
$-36.35M |
|
$-36.35M |
|
$-36.35M |
|
$-39.06M |
|
$-39.34M |
|
78.13M |
|
78.13M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$291.12M |
|
$2.76M |
|
$55.73M |
|
$346.86M |
|
$18.05M |
|
-- |
|
$4.81M |
|
$22.86M |
|
$323.99M |
|
$324.00M |
|
$324.00M |
|
86.19M |
|
| Cash Flow Statement Financials | |
$-63.38M |
|
$-54.48M |
|
$134.31M |
|
$59.90M |
|
$76.36M |
|
$16.46M |
|
$13.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-63.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.22% |
|
-11.22% |
|
-10.48% |
|
-11.22% |
|
$3.76 |
|
$-0.82 |
|
$-0.81 |
|